Skip to main content
. 2022 Mar 16;11(6):1003. doi: 10.3390/cells11061003

Figure 5.

Figure 5

Platelet-mediated antifungal activity in CLL patients (PT) under ibrutinib. Bar (A) and line graph (B) showing P-selectin expression in samples collected before starting ibrutinib and during the course of treatment (* p < 0.05; ** p < 0.01).